Riskpilot← Back to searchSign inGet full accessMediSupply ApS
APSActiveCVR 40490078Tårnvej 393Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employees
Revenue 2024
DKK 1,5M
+117% vs 2023
EBITDA margin
7.6%
-49% vs 2023
Equity ratio
49.1%
Financial strength
Net profit 2024
DKK 85K
-49% vs 2023
| Revenue | DKK 1,5M | +117% |
| EBITDA | DKK 111K | -49% |
| Net profit | DKK 85K | -49% |
| Total assets | DKK 613K | +43% |
| Equity | DKK 301K | +39% |
| Employees | 1 | — |
Legal name
MediSupply ApS
CVR number
40490078
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. maj 2019
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets hovedformål er at drive forretning og handel med læge- og hospitalsartikler herunder medicinsk udstyr og andre beslægtede produkter.
Derudover vil selskabet som bibranche drive virksomhed med praktiserende speciallæger samt yde konsultationer til private hospitaler og klinikker.
Address
Tårnvej 393
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 591 | 661 | 199 | 593 | 670 | 1.456 |
| Staff expenses | -0 | -0 | -88 | -74 | -453 | -1.344 |
| EBITDA | 591 | 661 | 111 | 519 | 217 | 111 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 591 | 661 | 111 | 519 | 217 | 111 |
| Net financials | -9 | -11 | -5 | -1 | -4 | -2 |
| Profit before tax | 582 | 650 | 106 | 518 | 212 | 109 |
| Tax | 129 | 145 | 24 | 114 | 47 | 24 |
| Net profit | 453 | 506 | 81 | 404 | 166 | 85 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 799 | 705 | 224 | 754 | 428 | 613 |
| Equity | 503 | 448 | 132 | 537 | 216 | 301 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 296 | 257 | 92 | 218 | 211 | 312 |
| Total debt | 296 | 257 | 92 | 218 | 211 | 312 |
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
20192024
Equity ratio
49.1%
This company
38.2%
Market median
+29% vs market
20192024
Return on equity
28.1%
This company
18.4%
Market median
+53% vs market
20192024
Net profit margin
5.8%
This company
8.1%
Market median
-28% vs market
20192024
Asset turnover
2.38×
This company
1.12×
Market median
+112% vs market
20192024
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-05-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MK Management | Management | 2019 | — | — |
AA Management | Management | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Blackridge Holdings ApS | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Blackridge Holdings ApS
MediSupply ApS Board members of MediSupply ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohamad Kadhem Mohamad Al-Jailawi | Management | 0 companies |
| Ahmad Al-Jailawi | Management | 0 companies |